Standard Chemical & Pharmaceutical Co. Ltd. Stock

Equities

1720

TW0001720001

Pharmaceuticals

End-of-day quote Taiwan S.E. 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
71.2 TWD +1.57% Intraday chart for Standard Chemical & Pharmaceutical Co. Ltd. +1.86% +8.04%
Sales 2024 * 6.8B 210M Sales 2025 * - Capitalization 12.72B 393M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.87 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 45.43%
More Fundamentals * Assessed data
Dynamic Chart
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Cash Dividend, Payable on August 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Appoints Lawrence C. Lee, Independent Director as Audit Committee Member, Effective June 20, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Elects One Additional Director and One Additional Independent Director CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces Executive Changes CI
Standard Chemical & Pharmaceutical Co. Ltd. Announces CFO Changes CI
Standard Chemical & Pharmaceutical Co. Ltd. Receives Resignation Letter from Chin-Tsai, Fan, the Chairman of the Board, Effective March 14, 2023 CI
Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Standard Chem & Pharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+1.57%
1 week+1.86%
Current month+1.86%
1 month+9.20%
3 months+8.87%
6 months+7.07%
Current year+8.04%
More quotes
1 week
69.40
Extreme 69.4
71.60
1 month
66.50
Extreme 66.5
77.70
Current year
60.50
Extreme 60.5
77.70
1 year
58.10
Extreme 58.1
77.70
3 years
36.80
Extreme 36.8
79.60
5 years
27.35
Extreme 27.35
79.60
10 years
24.10
Extreme 24.1
79.60
More quotes
Managers TitleAgeSince
Chief Executive Officer - 06-05-29
Director of Finance/CFO - 19-07-15
Corporate Officer/Principal - 01-03-31
Members of the board TitleAgeSince
Founder - 67-06-29
Director/Board Member - 02-05-28
Chief Executive Officer - 06-05-29
More insiders
Date Price Change Volume
24-06-07 71.2 +1.57% 900,133
24-06-06 70.1 -1.13% 473,007
24-06-05 70.9 0.00% 313,097
24-06-04 70.9 +1.29% 928,538
24-06-03 70 +0.14% 368,633

End-of-day quote Taiwan S.E., June 06, 2024

More quotes
Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
71.2 TWD
Average target price
80 TWD
Spread / Average Target
+12.36%
Consensus

Quarterly revenue - Rate of surprise